September 2024 Labs in Court
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing
Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation